by healthadvances Posted on April 10, 2018 PCSK9 Inhibitors’ Battle for Reimbursement: Germany’s Decision and Implications in Other Countries Read More
by healthadvances Posted on April 4, 2018April 5, 2018 Three Models for Population Health Technology Read More
by healthadvances Posted on April 3, 2018 Rare Disease Prevalence and Orphan Drug Pricing in Europe Read More
by healthadvances Posted on March 22, 2018April 10, 2018 Highlights of the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress Read More
by healthadvances Posted on March 14, 2018March 14, 2018 Seattle’s Journey to the Summit of Cancer Commercialization Read More
by healthadvances Posted on March 13, 2018 The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies Read More
by healthadvances Posted on February 16, 2018March 22, 2018 Why Flatiron’s Big Exit May Not Be the Boon for Digital Health That Some Expect Read More
